Cargando…
Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs
The data presented in this article support the accompanying research article “Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cance...
Autores principales: | Tarpley, Michael, Oladapo, Helen, Caligan, Thomas B., Onyenwoke, Rob U., Williams, Kevin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187839/ https://www.ncbi.nlm.nih.gov/pubmed/34141844 http://dx.doi.org/10.1016/j.dib.2021.107189 |
Ejemplares similares
-
Optimization and validation of a DYRK1A TR-FRET assay for high-throughput screening
por: Tarpley, Michael, et al.
Publicado: (2021) -
Data on peptides identified by mass spectrometry analysis of in vitro DYRK1A-mediated phosphorylation sites on GLI1
por: Ehe, Ben K., et al.
Publicado: (2017) -
Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
por: Uhl, Katie L., et al.
Publicado: (2018) -
β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
por: Frost, Danielle, et al.
Publicado: (2011) -
Data in support of a harmine-derived beta-carboline in vitro effects in cancer cells through protein synthesis
por: Carvalho, Annelise, et al.
Publicado: (2017)